Stockholm - Delayed Quote SEK
S2Medical AB (publ) (S2M.ST)
0.0212
-0.0012
(-5.36%)
At close: June 9 at 5:29:56 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
3,122
3,122
-16,519
-28,228.9620
-19,665.1850
Investing Cash Flow
-634
-634
-1,156
-1,761.5920
-3,023.9500
Financing Cash Flow
3,791
3,791
15,470
24,136.8210
6,847.8730
End Cash Position
1,005
1,005
1,517
3,722.9120
9,478.9520
Capital Expenditure
-634
-634
-1,156
-1,899.2030
-3,096.4500
Issuance of Capital Stock
4,369
4,369
22,001
22,512.0780
0
Issuance of Debt
0
0
9,052
2,500
10,000
Repayment of Debt
-578
-578
-10,879
-207.6920
-623.0770
Free Cash Flow
2,488
2,488
-17,675
-30,128.1650
-22,761.6350
12/31/2021 - 11/28/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IZAFE-B.ST iZafe Group AB (publ)
0.2540
+2.83%
ZJYL Jin Medical International Ltd.
0.6810
-11.52%
FEMY Femasys Inc.
0.8000
0.00%
GCTK GlucoTrack, Inc.
0.1510
+4.86%
POAI Predictive Oncology Inc.
0.9118
-2.86%
EKSO Ekso Bionics Holdings, Inc.
4.3100
+0.94%
HBIO Harvard Bioscience, Inc.
0.5583
+36.54%
STSS Sharps Technology, Inc.
5.86
-0.17%